Past scientific testimonials in the field of glioma research, the deadliest tumor among all
brain cancer types with the life span of 10-15 months after diagnosis is considered as …

Malignant peripheral nerve sheath tumors (MPNSTs) are rare but aggressive malignancies
with a low 5-year survival rate despite current treatments. MPNSTs frequently harbor …

Aim Despite current intensive therapy, survival rates of medulloblastoma (MB) greatly vary
according to molecular subgroup, so new therapies are needed. Recently, we showed that …

Objectives We aimed to use artificial intelligence to accurately identify molecular subgroups
of medulloblastoma (MB), predict clinical outcomes, and incorporate deep learning-based …

Methods A retrospective analysis was conducted, involving 284 patients treated at 21
pediatric oncology centers in Mexico. Results High-risk patients exhibited markedly lower …

A three-year-four-month-old boy with primary disseminated medulloblastoma M3 stage and
secondary occlusive hydrocephalus underwent an endoscopic triventriculocisternostomy …

Background: The management and consequent survival and quality of survival for young
children with medulloblastoma have undergone substantial improvement over the last four …

The SHh pathway plays a major role in a variety of different processes, ranging from
embryogenesis to the homeostasis maintenance of adult tissues, with Central Nervous …

This chapter delves into the structured framework of the World Health Organization (WHO)
classification of central nervous system CNS tumors. This chapter provides a systematic …

Background: Sonic hedgehog (SHH) medulloblastoma is the most common molecular group
of infant and early childhood medulloblastoma (iMB) and has no standard of care at relapse …